What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
His primary scientific interests are in Internal medicine, Endocrinology, Endothelium, Cardiology and Myocardial infarction.
In his works, he undertakes multidisciplinary study on Internal medicine and Xanthine oxidase.
His Endothelium research is multidisciplinary, incorporating perspectives in Endothelial stem cell, Superoxide dismutase, Scavenger receptor, Endothelial dysfunction and Nitric oxide.
His Cardiology study combines topics in areas such as Pulse wave velocity, Clinical endpoint, Surgery and Regeneration.
Within one scientific family, Ulf Landmesser focuses on topics pertaining to Shock under Myocardial infarction, and may sometimes address concerns connected to Conventional PCI.
The concepts of his Percutaneous coronary intervention study are interwoven with issues in ST segment, EuroSCORE and Cardiothoracic surgery.
His most cited work include:
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) (5768 citations)
- 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (3314 citations)
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (1782 citations)
What are the main themes of his work throughout his whole career to date?
Ulf Landmesser mainly focuses on Internal medicine, Cardiology, Endocrinology, Myocardial infarction and Coronary artery disease.
He integrates Internal medicine and In patient in his research.
His work deals with themes such as Prospective cohort study and Surgery, which intersect with Cardiology.
His Endocrinology study focuses mostly on Cholesterol, High-density lipoprotein, Lipoprotein, Nitric oxide and Endothelial dysfunction.
Ulf Landmesser frequently studies issues relating to Vasodilation and Endothelial dysfunction.
As part of his studies on Percutaneous coronary intervention, Ulf Landmesser frequently links adjacent subjects like Conventional PCI.
He most often published in these fields:
- Internal medicine (62.54%)
- Cardiology (38.40%)
- Endocrinology (17.08%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (62.54%)
- Cardiology (38.40%)
- In patient (11.29%)
In recent papers he was focusing on the following fields of study:
Ulf Landmesser spends much of his time researching Internal medicine, Cardiology, In patient, Myocardial infarction and Coronary artery disease.
His study in Heart failure, Acute coronary syndrome, Confidence interval, Hazard ratio and Disease is carried out as part of his Internal medicine studies.
The study incorporates disciplines such as Dyslipidemia, Lipid management, Low density lipoprotein cholesterol and Intensive care medicine in addition to Acute coronary syndrome.
Ulf Landmesser has included themes like Stroke and Randomized controlled trial in his Cardiology study.
Ulf Landmesser works on Myocardial infarction which deals in particular with Cardiogenic shock.
His Coronary artery disease research incorporates themes from Magnetic resonance imaging and Revascularization.
Between 2019 and 2021, his most popular works were:
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (215 citations)
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (135 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Gene
His primary areas of investigation include Internal medicine, Cardiology, Heart failure, Randomized controlled trial and Intensive care medicine.
His Disease study in the realm of Internal medicine connects with subjects such as Task force.
His work on Stroke prevention as part of general Cardiology research is often related to In patient, thus linking different fields of science.
Ulf Landmesser works mostly in the field of Heart failure, limiting it down to topics relating to Clinical endpoint and, in certain cases, Tricuspid valve, Ejection fraction, Interquartile range, Inferior vena cava and Severity of illness.
His Randomized controlled trial research includes elements of Regurgitation, Confidence interval, Myocardial infarction, Aortic valve stenosis and Lumen.
His work in Intensive care medicine covers topics such as Blood sampling which are related to areas like Cohort study, Observational Studies as Topic and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
